SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410578-19-000921
Filing Date
2019-08-26
Accepted
2019-08-26 17:28:47
Documents
14
Period of Report
2019-08-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv528310_8k.htm   iXBRL 8-K 25071
2 EXHIBIT 99.1 tv528310_ex99-1.htm EX-99.1 13250
6 GRAPHIC tv528310_img01.jpg GRAPHIC 7213
  Complete submission text file 0001410578-19-000921.txt   224111

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA qure-20190820.xsd EX-101.SCH 3183
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE qure-20190820_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qure-20190820_pre.xml EX-101.PRE 22708
7 EXTRACTED XBRL INSTANCE DOCUMENT tv528310_8k_htm.xml XML 3353
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-36294 | Film No.: 191053793
SIC: 2834 Pharmaceutical Preparations